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Objectives
To determine the discrimination characteristics of a new algorithm and two existing symptom scoring systems for identification of patients with suspected colorectal cancer.
Design
Derivation of algorithm by a case-control study and assessment of discrimination characteristics using receiver operating characteristics (ROC) curves. Three colorectal cancer scoring systems were investigated. The Bristol-Birmingham (BB) equation, which we derived from a large primary care dataset; the CAPER score, previously derived from a primary care case-control study and a symptom score derived from National Institute of Clinical Excellence (NICE) guidance for urgent referral of symptomatic patients. Their discrimination characteristics were investigated in two datasets: the BB derivation dataset and the CAPER score derivation dataset. The main analyses were ROC curves and the areas under them for all three algorithms in both datasets.
Setting
Electronic primary care databases
Main outcome measures
Diagnosis of colorectal cancer
Results
In the BB dataset, areas under the curve were: BB equation 0.83 (95% CI: 0.82 to 0.84); CAPER 0.79 (95% CI: 0.79 to 0.80); the NICE guidelines 0.65 (95% CI: 0.64 to 0.66). In the CAPER dataset, areas under the curve were: BB 0.92 (95% CI 0.91 to 0.94); CAPER 0.91 (95% CI 0.89 to 0.93); NICE guidelines 0.75 (95% CI 0.72 to 0.79). In subjects under 50 the discrimination characteristics of NICE referral guidelines were no better than chance.
Conclusions
Both multivariable symptom scoring systems performed significantly better than NICE referral guidelines.
What this paper adds
What is already known on this subject Despite the availability of screening, the majority of colorectal cancers will continue to be diagnosed after presentation with symptoms Selection of patients for further investigation depends on combining information from a number of symptoms and signs
The existing symptom scoring systems (NICE guidance and the CAPER score) to help primary care physicians identify which patients should be referred for further investigation have not been evaluated.
What this study adds
Both the new Bristol-Birmingham equation and the CAPER score are markedly better at discriminating between patients with and without colorectal cancer than current NICE guidelines In patients aged under 50 years current NICE guidelines for urgent referral have no ability to discriminate between patients with and without colorectal cancer
Introduction
Colorectal cancer remains an important cause of death in the UK. Poorer survival rates in international comparisons may be influenced by later presentation. [1] [2] [3] Delays in presentation to medical care and diagnosis are well recognised. 4 Despite introduction of a national screening programme in the UK for those aged 60 to 69, the majority of cancers will continue to be diagnosed clinically because most cancers occur after this age, some decline screening, and screening does not detect all cancers.
5
Diagnosis of colorectal cancer is difficult because the condition is relatively uncommon in primary care and the symptoms are also features of more common, benign conditions. A typical full-time general practitioner will diagnose only one new case annually. 6 Colonoscopy is the main diagnostic test for suspected colorectal cancer, but this is an uncomfortable procedure, requires referral and has a small rate of important complications.
There are a number of different approaches to helping general practitioners select patients for further investigation. Single symptoms have a low specificity for colorectal cancer, but symptom pairs may have more useful test characteristics. [7] [8] The National Institute for Clinical Excellence (NICE) published national Referral Guidelines for Suspected Cancer in 2000, and updated these in 2005. 9 These use an algorithm based on age and the presence of certain clinical features. However the guidelines concentrate on typical presentations of cancer; it has been argued that they may even delay diagnosis in patients with atypical presentations. 10 Although the guidelines do not recommend referral of patients with constipation or abdominal pain, these features are clearly associated with cancer. 5 10 It is possible that current referral guidance will reinforce the finding that diagnostic delay is most common in patients who present with change of bowel habit.
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The CAPER score is a risk scoring system using multiple presenting symptoms. 12 It was derived from a primary care based case-control study in a single primary care trust. 13 The CAPER score itself is intended for use with patients without these high-risk features, but who have multiple low-risk symptoms. The score seeks to identify those at higher risk from this low-risk pool. The weaknesses of the CAPER study were that it was undertaken in a single geographical area, used paper-based records and was relatively small. 12 This paper describes the derivation of the Bristol-Birmingham (BB) equation and compares its performance to the NICE referral guidelines and the CAPER score, using the two different datasets used to derive the BB equation and the CAPER score. Three risk markers (as opposed to diagnostic features) were also studied: diabetes, obesity and deprivation. For diabetes, patients were considered to be exposed if they had been diagnosed with diabetes at any time before the index date. Obesity was defined as a body mass index greater than 30kg/m 2 within two years of the index date. Each patient was allocated a deprivation quintile based on the Townsend score of their postcode. Irritable bowel syndrome is a potential misdiagnosis: we identified all patients with a record of this diagnosis at any time.
Materials and Methods
Derivation of the BB equation: identification of cases, controls and variables
Derivation of the BB equation: data analysis
The initial analysis used univariable conditional logistic regression. Several variables were combined after initial analyses. As the odds ratios for diarrhoea, constipation and abdominal pain were similar to the odds ratios for the related prescription for these symptoms, the pairs of variables were combined. From now on when we use the terms diarrhoea, constipation or abdominal pain, we are referring to either the symptom or a new related prescription for the symptom. The odds ratios for weight loss without a recorded weight were similar to that for ≥10% weight loss; for a haemoglobin result >14g/dl similar to that for no haemoglobin result; for a MCV >85 fl similar to that for no MCV result. These categories were combined.
Variables associated with colorectal cancer with a p-value ≤0.1 were entered into multivariable conditional logistic regression analyses. The model included the following variables: constipation, diarrhoea, change in bowel habit, flatulence, a diagnosis of irritable bowel syndrome, abdominal pain, rectal bleeding, haemoglobin concentration (in 1g/dl bands), microcytosis in two bands (mean cell volume <80 fl and 80-84.99 fl), weight loss (<5%, 5% to 9.9% and 10%), venous thrombosis or thromboembolism, diabetes and obesity.
The first stage of the multivariable analysis included only symptoms in clinically related groups: intestinal motility symptoms included constipation, diarrhoea, change in bowel habit and flatulence; pain symptoms included irritable bowel syndrome and abdominal pain;
bleeding symptoms included rectal bleeding, anaemia and microcytosis; systemic symptoms included weight loss and thromboembolism; obesity symptoms included diabetes and obesity.
The next stage included included all symptoms. Variables where the p-value was greater than 0.05 at any stage, including the final model, were excluded, though these were checked by adding them individually to the final model, using likelihood ratio testing.
Discrimination characteristics
To investigate the discrimination characteristics of the BB equation, individuals in the test dataset were allocated a score equal to their multivariable odds ratio. Because patients with a positive faecal occult blood test, or an abnormal rectal examination, or an abdominal mass unquestionably qualify for further investigation they were allocated an arbitrary maximum score of 100 points in order to make them the highest priority for referral. In this way the score reflected relative priority for further investigation.
The CAPER scores of participants in this study were derived from the presence or absence of six features of colorectal cancer -constipation (25 points), diarrhoea (10), loss of weight (20) , abdominal pain or tenderness (15) , and one laboratory finding -low haemoglobin (10-11.9g/dl 30 points; 12-12.9g/dl 20 points). The CAPER system was derived for use in a population with only low-risk symptoms, with investigation suggested for scores of ≥35
points. Patients with abnormal rectal examination, severe anaemia (haemoglobin <10 g/dl) or rectal bleeding were considered to need referral, so were also allocated an arbitrary score of 100 ( Table 2 ).
The NICE guidelines offer a binary choice: urgent referral or no urgent referral -on the basis of a series of categorical variables: age over 40 years, age over 60 years, sex, menopausal status, diarrhoea (looser stools or increasing stool frequency) of six weeks' duration, rectal bleeding, abdominal mass, abnormal rectal examination and anaemia. Urgent referral is recommended for patients aged over 60 years with increased stool frequency or with rectal bleeding for six weeks; aged over 40 years with increased stool frequency and rectal bleeding for six weeks; with an abdominal mass or abnormal rectal examination; iron deficiency anaemia (Hb <11mg/dl) in men; iron deficiency anaemia (Hb <10mg/dl) in postmenopausal women.
In the main analysis (NICE 3) we interpreted NICE guidance as follows. The occurrence of two consultations with diarrhoea or change in bowel habit separated by more than 35 but less than 120 days was considered to indicate increased stool frequency for at least six weeks.
Consultations separated by more than 120 days are likely to be separate episodes. A single consultation with rectal bleeding was taken to indicate rectal bleeding for at least six weeks.
We again assigned a score of 100 points for abdominal mass, positive faecal occult blood or abnormal rectal examination for consistency. We assigned one point for the following features in which urgent investigation is advised: diarrhoea plus rectal bleeding and aged over 40 years; rectal bleeding and aged over 60; diarrhoea and aged over 60; haemoglobin <11g/dl with microcytosis in a man; and haemoglobin <10g/dl with microcytosis in a postmenopausal woman (age>52 was taken as a proxy for being postmenopausal). The score thus rose with the number of qualifying symptoms (Table 2 ). In the CAPER dataset, the mean cell volume was not available, so the requirement for microcytosis was dropped; therefore a haemoglobin <10 g/dl in a man was allocated one point.
Two sensitivity analyses used different interpretations of the NICE guidelines. In NICE 1, a single consultation with diarrhoea or change in bowel habit was taken to indicate diarrhoea for six weeks. In NICE 2, two consultations separated by more than 35 but less than 120 days but not change in bowel habit, were taken to indicate diarrhoea for six weeks.
The receiver operating characteristics of a prediction model are usually superior in the dataset from which it was derived. To avoid this "home advantage", two datasets were used to assess the predictive power of the equations: the dataset used to derive the BB equation (described above) and the CAPER dataset. The CAPER dataset includes 349 colorectal cancer cases and 1744 age and sex matched controls. 8 The mean age of cases was 71.9 years (range 40 to 96) and 50.1% of the dataset was male. The CAPER dataset was obtained by searching both paper and electronic primary care records for symptoms. In the CAPER dataset, weight loss was recorded as only present or absent; therefore this was taken to be equivalent to a >10% weight loss.
Receiver operating characteristics (ROC) curves were constructed and the area under the curve was determined for the three prediction models in both datasets. The large size of the THIN dataset allowed us to undertake extensive sensitivity analyses. We repeated ROC curves for men and women, for each year of diagnosis of cancer from 2001 to 2007 and in ten year age bands. To determine whether allocating a "mandatory referral" score to abdominal masses, positive faecal occult bloods or abnormal rectal examinations affected the findings,
we excluded cases and controls with these features and repeated the analysis. Because the CAPER score was derived from persons aged 40 and over we also repeated the analysis in persons aged over 40.
Yield
We estimated the yield of colorectal cancers using these systems by calculating the positive predictive values (PPVs) at selected points of the ROC curves, using Bayes' theorem (posterior odds = prior odds×likelihood ratio). 17 To compare the systems, we used the points on the three ROC curves with the same sensitivity. We derived the prior odds from national incidence rates for 2006, stratified by age and sex. 18 
Results
We identified 5,477 cases and 38,314 controls in a total of 317 practices. Their mean age was 70.6 years (range 30 to 105) and 53.1% were male. Demographic details of subjects are shown in Table 1 .
Derivation of the BB equation
In the univariable analyses, positive faecal occult bloods (odds ratio 24. were strongly associated with a diagnosis of colorectal cancer. (Table 3 ) As these features warrant investigation per se they were dropped from further modelling. A family history of colorectal cancer was recorded in only seven cases and eight controls (odds ratio 6.13 95% CI
to 16.9).
Multivariable analysis was carried out using 13 variables, plus the deprivation quintile. In multivariable analyses none of flatulence, irritable bowel syndrome, diabetes, obesity, thromboembolism, or deprivation quintile was independently associated with cancer. The final model therefore included eight variables: constipation, diarrhoea, change in bowel habit, abdominal pain, haemoglobin concentration mean cell volume and weight loss (Table 4) . Table 2 
Discrimination characteristics 1. In the BB dataset
Discrimination characteristics 2. In the CAPER dataset
In the CAPER dataset, the areas under the curve were BB 0.92 (95% CI 0.91 to 0.94);
CAPER 0.91 (95% CI 0.89 to 0.93); NICE 1 0.76 (95% CI 0.73 to 0.80). (Table 5 ) In this dataset the area under the curve for NICE 1 was greater than for NICE 3. (Figure 2 )
Yield
Using the more conservative estimate of discrimination characteristics derived from the THIN dataset, NICE 3 has a sensitivity of 0.327 and a specificity of 0.974, giving a positive likelihood ratio of 12.5 and a positive predictive value (yield) of 3.1% at age 70-74. A point on the CAPER and BB ROC curves for the same age was selected to have the same sensitivity. These points had the following characteristics: CAPER -positive likelihood ratio 13.4 and PPV 3.3%.; BB -positive likelihood ratio 14.7 and PPV 3.7%. (Table 6 )
Discussion
In both datasets the overall discrimination characteristics of the BB equation were consistently slightly better than those of the CAPER score and both were superior to any of the interpretations of current guidance. NICE guidelines performed no better than chance in subjects aged under 50.
Weakness and strengths
The performance of all methods of identifying colorectal cancer was better in the CAPER dataset than in the THIN dataset. The CAPER dataset has some probable advantages: cases were identified from the cancer registry and clinical features of colorectal cancer were identified from both paper and electronic records. 12 The overall standardised incidence of cancer in THIN is consistent with cancer registry data, but there is some under-recording, We did not use the 'free text' comments in the THIN records. 20 This will have meant some symptom recording was missed, though there is no reason to believe this would be more common in cases than controls.
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Comparison with previous literature NICE guidelines may perform less well than the BB equation and CAPER because they include fewer predictor variables, some of which only apply at certain ages. This means that NICE guidelines perform well for the minority of colorectal cancers with typical features (the first part of the ROC curve), but less well for the majority of cases with low risk but not norisk symptoms. 21 Variables absent from NICE guidelines include constipation, loss of weight and abdominal pain. Diarrhoea, rectal bleeding and anaemia are part of CAPER and BB at all ages, though have an age-restriction within NICE. The BB equation includes two further variables, microcytosis and change in bowel habit and divides haemoglobin level and weight loss into subcategories. Change in bowel habit is an important predictor of colorectal cancer, and clearly doctors use this term differently to either diarrhoea or constipation. One criticism of NICE guidance is that only the minority of patients with colorectal cancer have a high risk symptom before diagnosis, with the majority experiencing constipation, diarrhoea or abdominal pain (or a combination of these). 5 Thus, it is not surprising that NICE fails to identify such patients, and that survival from colorectal cancer has improved little since they were published.
Other referral guidelines and symptom scoring systems might be investigated in a similar way. For example, the Selva score was derived from patients referred to secondary care for investigation and makes use of a consultation questionnaire to elicit symptoms. 22 It has been reported to have an area under the curve of 0.76 in a population of patients referred for investigation of suspected colorectal cancer 23 though it had a very poor performance in the one reported primary care study. 24 Primary care datasets are an invaluable resource for investigating the discrimination characteristics of referral guidelines and therefore of informing recommendations.
Multivariable models to guide referral have much better discrimination characteristics than current NICE guidelines and so have the potential to significantly improve the selection of patients for further investigation of colorectal cancer symptoms. There is a strong case for a cohort analysis to derive a statistical model of cumulative incidence of colorectal cancer. 
